HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ogi-keishi-gomotsu-to-ka-kojin

contains Astragalus membranaceus, Cinnamomum cassia, Paeonia lactiflora, Zingiber officinale, Zizyphus jujuba & Panax ginseng

Also Known As:

OKGK drug

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        ogi-keishi-gomotsu-to-ka-kojin: 3
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - ogi-keishi-gomotsu-to-ka-kojin: 3

Related Diseases

1.	Hyperlipidemias (Hyperlipidemia) 12/01/1997 - "The antihyperlipidemic action of Ogi-Keishi-Gomotsu-To-Ka-Kojin (OKGK) was examined in rats with experimentally-induced hyperlipidemia. " 05/01/1999 - "The effect of Ogi-Keishi-Gomotsu-To-Ka-Kojin (OKGK), a Japanese traditional herbal medicine (Kampo medicine), has been studied in a cyclophosphamide (CPM)-induced hyperlipidemia model in fasted rabbits. " 05/01/1999 - "Antihyperlipidemic action of Ogi-Keishi-Gomotsu-To-Ka-Kojin against cyclophosphamide-induced hyperlipidemia in rabbits."
2.	Hypertriglyceridemia 09/01/1999 - "Ogi-Keishi-Gomotsu-To-Ka-Kojin (OKGK) is a traditional herbal medicine (Kampo medicine) which has been found to ameliorate hypercholesterolemia and hypertriglyceridemia in rats and rabbits. "
3.	Hypercholesterolemia 09/01/1999 - "Ogi-Keishi-Gomotsu-To-Ka-Kojin (OKGK) is a traditional herbal medicine (Kampo medicine) which has been found to ameliorate hypercholesterolemia and hypertriglyceridemia in rats and rabbits. "

Related Drugs and Biologics

1.	Hypolipidemic Agents (Antihyperlipidemics)
2.	Cyclophosphamide (Cytoxan)

Related Therapies and Procedures

1.	Kampo Medicine (Kampo)